Cargando…

A Novel Mechanical-Based Injective Hydrogel for Treatment with Aromatase Inhibitors Caused Joint Inflammation via the NF-κB Pathway

[Image: see text] Synovium has widely participated in induced inflammation, suggesting that it is a potential target to reduce aromatase inhibitors (AIs) causing joint inflammation or pain. Exercise and mechanical stimulation are important strategies for precaution and treatment of bone inflammation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Zipeng, Xu, Chang-Peng, Chen, Yuhui, Li, Wenqiang, Wang, Liping, Yuan, Zi-Guo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153782/ https://www.ncbi.nlm.nih.gov/pubmed/34056178 http://dx.doi.org/10.1021/acsomega.1c00580

Ejemplares similares

Progesterone attenuates temporomandibular joint inflammation through inhibition of NF-κB pathway in ovariectomized rats
por: Xue, Xin-Tong, et al.
Publicado: (2017)

Does Aromatase Inhibitors Cause Sjogren’s Syndrome and Polyneuropathy?
por: Yasar Bilge, Nazife Sule, et al.
Publicado: (2014)

Sequencing of aromatase inhibitors
por: Bertelli, G
Publicado: (2005)

Morin Inhibits Dox-Induced Vascular Inflammation By Regulating PTEN/AKT/NF-κB Pathway
por: Yu, Jing, et al.
Publicado: (2022)

Inhibition of HMGB1 suppresses inflammation and catabolism in temporomandibular joint osteoarthritis via NF-κB signaling pathway
por: Li, Yan Yan, et al.
Publicado: (2022)

NF-κB signaling pathway mechanism in cow intertoe skin inflammation caused by Fusobacterium necrophorum
por: Zhang, Hefei, et al.
Publicado: (2023)

Bone loss and the aromatase inhibitors
por: Lester, J, et al.
Publicado: (2005)

Aromatase inhibitors in male sex
por: Singh, Santosh Kumar
Publicado: (2013)

Aromatase inhibitors in the treatment of endometriosis
por: Słopień, Radosław, et al.
Publicado: (2016)

Molecular Docking of Aromatase Inhibitors
por: Suvannang, Naravut, et al.
Publicado: (2011)

Aromatase Inhibitors in Erectile Dysfunction
por: Singh, Santosh
Publicado: (2021)

Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors
por: Chim, Kannie, et al.
Publicado: (2013)

Small Molecule NF-κB Pathway Inhibitors in Clinic
por: Ramadass, Venkataramanan, et al.
Publicado: (2020)

Tanreqing Injection Attenuates Lipopolysaccharide-Induced Airway Inflammation through MAPK/NF-κB Signaling Pathways in Rats Model
por: Liu, Wei, et al.
Publicado: (2016)

Intra-bone marrow injection of magnesium isoglyrrhizinate inhibits inflammation and delays osteoarthritis progression through the NF-κB pathway
por: Chen, Rong, et al.
Publicado: (2022)

Aromatase and Dual Aromatase-Steroid Sulfatase Inhibitors from the Letrozole and Vorozole Templates
por: Wood, Paul M, et al.
Publicado: (2011)

NF-κB signaling in inflammation
por: Liu, Ting, et al.
Publicado: (2017)

Effect of aromatase inhibitor letrozole on the proliferation of spermatogonia by regulating the MAPK pathway
por: Wang, Shunde, et al.
Publicado: (2018)

Joint Symptoms, Aromatase Inhibitor-Related Adverse Reactions, Are Indirectly Associated with Decreased Serum Estradiol
por: Honda, Junko, et al.
Publicado: (2011)

Role of aromatase inhibitors in breast cancer
por: Carpenter, R, et al.
Publicado: (2005)

The effects of aromatase inhibitors on lipids and thrombosis
por: Bundred, N J
Publicado: (2005)

Safety of aromatase inhibitors in the adjuvant setting
por: Perez, Edith A.
Publicado: (2007)

Aromatase inhibitors--where are we now?
por: Miller, W. R.
Publicado: (1996)

Aromatase inhibitors in stimulated IVF cycles
por: Papanikolaou, Evangelos G, et al.
Publicado: (2011)

Aromatase inhibitors in post-menopausal endometriosis
por: Polyzos, Nikolaos P, et al.
Publicado: (2011)

Management of aromatase inhibitor–induced arthralgia
por: Younus, J., et al.
Publicado: (2010)

Understanding the mechanisms of aromatase inhibitor resistance
por: Miller, William R, et al.
Publicado: (2012)

Use of aromatase inhibitors in practice of gynecology
por: Usluogullari, Betul, et al.
Publicado: (2015)

Safety of aromatase inhibitors in the adjuvant setting
por: Perez, Edith A.
Publicado: (2007)

Precautions for Patients Taking Aromatase Inhibitors
por: Heery, Mary, et al.
Publicado: (2020)

The Role of Aromatase Inhibitors in Male Prolactinoma
por: Akirov, Amit, et al.
Publicado: (2023)

The TRAF6-NFκB signaling pathway in autoimmunity: not just inflammation
por: Thomas, Ranjeny
Publicado: (2005)

Microglia promote autoimmune inflammation via the noncanonical NF-κB pathway
por: Jie, Zuliang, et al.
Publicado: (2021)

NF-κB in inflammation and renal diseases
por: Zhang, Haisong, et al.
Publicado: (2015)

NF-κB: At the Borders of Autoimmunity and Inflammation
por: Barnabei, Laura, et al.
Publicado: (2021)

NF‐κB signaling in inflammation and cancer
por: Zhang, Tao, et al.
Publicado: (2021)

Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment
por: Wang, Tao, et al.
Publicado: (2022)

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
por: Jayaraman, Swaathi, et al.
Publicado: (2020)

Aromatase-Inhibitor-Induced Musculoskeletal Inflammation Is Observed Independent of Oophorectomy in a Novel Mouse Model
por: Young, Nicholas A., et al.
Publicado: (2022)

Biomechanical Thresholds Regulate Inflammation through the NF-κB Pathway: Experiments and Modeling
por: Nam, Jin, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_9e3mf7o0jcmma54to2vco6nnh2